Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GNMSF) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to 0.45.

  • Genmab A's Equity Ratio fell 4328.83% to 0.45 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.45, marking a year-over-year decrease of 4328.83%. This contributed to the annual value of 0.45 for FY2025, which is 4328.83% down from last year.
  • Latest data reveals that Genmab A reported Equity Ratio of 0.45 as of Q4 2025, which was down 4328.83% from 0.82 recorded in Q3 2025.
  • Genmab A's Equity Ratio's 5-year high stood at 0.9 during Q4 2023, with a 5-year trough of 0.45 in Q4 2025.
  • Over the past 3 years, Genmab A's median Equity Ratio value was 0.8 (recorded in 2024), while the average stood at 0.78.
  • The largest annual percentage gain for Genmab A's Equity Ratio in the last 5 years was 230.33% (2025), contrasted with its biggest fall of 4328.83% (2025).
  • Quarter analysis of 3 years shows Genmab A's Equity Ratio stood at 0.9 in 2023, then fell by 10.6% to 0.8 in 2024, then tumbled by 43.29% to 0.45 in 2025.
  • Its last three reported values are 0.45 in Q4 2025, 0.82 for Q3 2025, and 0.82 during Q2 2025.